Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy (AVERT)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Mayo Clinic
Comprehensive Cancer Center of Wake Forest University
Norris Cotton Cancer Center
University of Massachusetts, Worcester
Information provided by (Responsible Party):
Steven Ades, University of Vermont
ClinicalTrials.gov Identifier:
NCT00970905
First received: August 25, 2009
Last updated: December 27, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)